Activation products of the haemostatic system in coronary, cerebrovascular and peripheral arterial disease. [electronic resource]
- Thrombosis and haemostasis Feb 2001
- 234-9 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0340-6245
Aged Aged, 80 and over Analysis of Variance Antifibrinolytic Agents--adverse effects Antithrombin III Arterial Occlusive Diseases--blood Case-Control Studies Cerebrovascular Disorders--blood Cohort Studies Coronary Disease--blood Cross-Sectional Studies Female Fibrin Fibrinogen Degradation Products--metabolism Fibrinolysin Humans Male Middle Aged Peptide Fragments--blood Peptide Hydrolases--blood Peripheral Vascular Diseases--blood Prothrombin Vascular Diseases--blood alpha-2-Antiplasmin